Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host …

M Nygaard, T Karlsmark, NS Andersen… - Bone Marrow …, 2019 - nature.com
Improvement in chronic graft vs. host disease (cGvHD) following treatment with
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

E Kansu, D Ward, AP Sanchez, R Cunard, M Hayran… - …, 2022 - Taylor & Francis
Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: prospective single‐center study

I Sakellari, E Gavriilaki, I Batsis… - Journal of Clinical …, 2018 - Wiley Online Library
Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …

[HTML][HTML] Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis …

HT Greinix, K van Besien, AH Elmaagacli… - Biology of Blood and …, 2011 - Elsevier
In a prior multicenter randomized controlled trial, we found that a 12-week course of
extracorporeal photopheresis (ECP) plus standard immunosuppressive therapy resulted in …

Extracorporeal photopheresis in acute and chronic graft-versus-host disease

HT Greinix, N Worel, U Just, R Knobler - Transfusion and Apheresis …, 2014 - Elsevier
Graft-versus-host disease (GvHD) is a serious complication of allogeneic hematopoietic cell
transplantation causing significant morbidity and mortality. Corticosteroids are the …

Response of steroid‐refractory chronic graft‐versus‐host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during …

G Bertani, L Santoleri, U Ferri, P Marenco, G Grillo… - …, 2016 - Wiley Online Library
BACKGROUND Extracorporeal photopheresis (ECP) is a recognized second‐line treatment
for steroid‐refractory chronic graft‐versus‐host disease (cGVHD). Treatment course is …

Extracorporeal photochemotherapy for the treatment of chronic graft‐versus‐host disease: trend for a possible cell dose‐related effect?

P Perseghin, S Galimberti, A Balduzzi… - Therapeutic …, 2007 - Wiley Online Library
Extracorporeal photochemotherapy (ECP) has been progressively introduced into the
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …

The role of extracorporeal photopheresis in chronic graft-versus-host disease

V Radojcic, MA Pletneva, DR Couriel - Transfusion and Apheresis Science, 2015 - Elsevier
Chronic graft-versus-host disease (GVHD) is the most important cause of late morbidity and
mortality in recipients of allogeneic blood and marrow transplantation. Despite increased …

Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology

P Tsirigotis, P Kaloyannidis, A Papalexandri… - … and Apheresis Science, 2012 - Elsevier
The Hellenic experience regarding the efficacy of extracorporeal photopheresis (ECP) in the
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …

[HTML][HTML] Retrospective multicenter study of extracorporeal photopheresis in steroid-refractory acute and chronic graft-versus-host disease

G Oarbeascoa, ML Lozano, LM Guerra… - Biology of Blood and …, 2020 - Elsevier
Extracorporeal photopheresis (ECP) is an established treatment strategy in steroid-refractory
graft-versus-host disease (GVHD). This study's main objective was to analyze the clinical …